Especially when it comes to bimodal IT there have been a lot of heated discussions recently. This can be quite a contentious issue – some have good arguments why bimodal IT can be risky for organizations. Notably a two-class system is feared, in which investment in “slow IT“ is neglected. On the other side our client Axel Springer is one example showing that separating slow from fast IT can be the best way to deal with the current IT landscape – if you manage to link up both aspects.
Gartner says that today 70% of Enterprise Architects are taking on a major role in digital transformation already. We can see the opportunities given by lean EAM to companies in the digital transformation but can also see that the implementation will pose challenges. That is why LeanIX is offering companies an affordable tool that can be used immediately to support this process in the best way possible.
Want to know more? Download our whitepaper on the role of EAM in the digital transformation or visit our booth during the Gartner EA Summit to see a live demo of LeanIX.
Can't wait until the Gartner EA Summit? Request your FREE LEANIX DEMO now!
2024 Gartner® Magic Quadrant™ for Enterprise Architecture Tools
SAP LeanIX named a Leader in the 2024 Gartner® Magic Quadrant™ for Enterprise Architecture Tools for fourth consecutive year
DISCLAIMER: This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from SAP LeanIX. SAP acquired LeanIX in 2023. Recognized as LeanIX in the Magic Quadrant for Enterprise Architecture Tools (2021-2023). Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.